Asterias Biotherapeutics Inc (AST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,097 | -6,771 | -5,089 | -2,287 | -22,380 |
| Depreciation Amortization | 5,404 | 2,584 | 1,720 | 877 | 1,031 |
| Income taxes - deferred | -7,376 | -5,175 | -2,862 | -1,349 | -3,281 |
| Accounts payable and accrued liabilities | 120 | -181 | -313 | -81 | 567 |
| Other Working Capital | -1,336 | -1,806 | 3,292 | 1,051 | 5,142 |
| Other Operating Activity | 1,694 | 1,581 | 1,318 | 339 | 17,594 |
| Operating Cash Flow | $-11,591 | $-9,768 | $-1,934 | $-1,449 | $-1,327 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,661 | 12,661 | 12,661 | N/A | N/A |
| PPE Investments | -334 | -200 | -198 | -97 | -1,219 |
| Purchase Of Investment | N/A | -307 | -307 | -300 | -55 |
| Other Investing Activity | -307 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $12,020 | $12,154 | $12,156 | $-397 | $-1,274 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 476 | 468 | 468 | N/A | 5,000 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -228 |
| Financing Cash Flow | $476 | $468 | $468 | $N/A | $4,772 |
| Beginning Cash Position | 2,171 | 2,171 | 2,171 | 2,171 | N/A |
| End Cash Position | 3,076 | 5,025 | 12,861 | 326 | 2,171 |
| Net Cash Flow | $905 | $2,854 | $10,690 | $-1,845 | $2,171 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,591 | -9,768 | -1,934 | -1,449 | -1,327 |
| Capital Expenditure | -334 | -200 | -198 | -97 | -1,247 |
| Free Cash Flow | -11,925 | -9,968 | -2,132 | -1,545 | -2,574 |